Arezoo Esmaeili | Molecular Biology | Best Researcher Award

Ms. Arezoo Esmaeili | Molecular Biology | Best Researcher Award

Islamic Azad University | Iran

Ms. Arezoo Esmaeili is a senior researcher in viral immunology and cancer biology based in Mashhad, Iran, with over 13 years of experience in translational research focusing on EBV-, CMV-, and HCV-associated diseases. She holds an MSc in Biotechnology-Microbial from Islamic Azad University, Damghan Branch, and a BSc in Cellular and Molecular Biology-Microbiology. Her expertise lies in designing and evaluating peptide-based vaccines and immunotherapies targeting viral antigens in cancer, with notable publications including systematic reviews on peptide vaccines, viral reactivation post-COVID-19, and the role of Epstein–Barr virus in programmed cell death and cancer development. Ms. Arezoo Esmaeili has led cross-disciplinary R&D projects as Research and Development Manager at Mashhad Pharma Co., guided biomedical research at Zist Fan Teb Co., and managed translational research projects at Mojrian Salamat Farandishan Co. She is skilled in molecular biology techniques, vaccine design, bioinformatics, and research translation, and actively contributes as a peer reviewer for international journals, participates in global conferences, and pursues cutting-edge training in mRNA technology, immunogenomics, and cancer therapeutics.

Profile: Google Scholar

Featured Publications

  • Amel Jamehdar, S., Tabaei, S., Mashkani, B., Karimi, R., Motallebnezhad, M., & Esmaeili, A. (2019). Construction of Epstein–Barr virus cocktail peptide fused with Fcγ of IgG: As a potential delivery system for vaccine development. Bioengineered, 10(1), 689–696.

  • Jamal, M. K., Sanaei, B., Naderi, M., Past, V., Abadi, S. H. A., Khazaei, R., & Esmaeili, A. (2025). Investigating the recent outbreak of dengue fever in Iran: A systematic review. The Egyptian Journal of Internal Medicine, 37(1), 1–21.

  • Esmaeili, A., Awasthi, P., & Tabaee, S. (2025). Beyond immortality: Epstein–Barr virus and the intricate dance of programmed cell death in cancer development. Cancer Treatment and Research Communications, 43, 100880.

  • Naderi, M., Naderi, M., Keramati Jamal, M., Past, V., Esmaeili, A., Khabazian, A., Hashemi Ali Abadi, S., Saremi, G., Asghari, Sh., & Moghimi, Sh. (2025). The reactivation of various viruses following COVID-19 infection: A systematic review. Future Virology, 20(3–4), 99–111.

  • Tabaei, S., Mashkani, B., Esmaili, A., Karimi, R., & Jamehdar, S. A. (2016). Design of cocktail peptide vaccine against Cytomegalovirus infection. Iranian Journal of Basic Medical Sciences, 19(4), 449–454.

Workisa Chala Bulto | Molecular Characterization | Best Researcher Award

Mr. Workisa Chala Bulto | Molecular Characterization | Best Researcher Award

Mr. Workisa Chala Bulto, National Veterinary Institute, Ethiopia

Evaluation of Mr. Workisa Chala Bulto for the Best Researcher Award

Publication profile

Professional Experience

Mr. Workisa has extensive experience in the veterinary field, currently serving as a Senior Laboratory Officer at the National Veterinary Institute (NVI) of Ethiopia since May 2017. His responsibilities include performing quality control activities to ensure the production of high-quality vaccines. Prior to this, he was a Laboratory Animals Health Officer at NVI, where he managed the health of laboratory animals used for vaccine safety trials. His earlier roles include serving as a Research Assistant at the Ethiopian Institute of Agricultural Research and as a Development Agent in Guduru woreda, focusing on animal science training.

Educational Background

Mr. Workisa holds a Master of Veterinary Science (MVSc) in Veterinary Microbiology from Addis Ababa University, with his thesis focusing on the outbreak investigation and molecular detection of Lumpy Skin Disease Virus in cattle. He also earned a Bachelor of Veterinary Science (BVSc) from Haramaya University, graduating with high distinction (CGPA=3.89), and a Diploma in Animal Science from Alage ATVET College, also with very high distinction (CGPA=3.93).

Skills and Certifications

Mr. Workisa has obtained various certifications in areas such as Biologicals GMP Inspection, risk management, quality management systems, and current good manufacturing practices (cGMP). His training also includes scientific report writing, experimental design, and sheep reproduction techniques.

Research and Publications

Mr. Workisa has contributed to several research projects, including studies on the seroprevalence of small ruminant brucellosis and the effect of improved feeding management on Afar bulls. His recent work includes an unpublished study on the molecular detection of the Lumpy Skin Disease Virus.

Publication Top Notes

  • 🦠📅 2024 – “Outbreak Investigation, Isolation, and Molecular Characterization of Lumpy Skin Disease Virus in Cattle from North West Oromia Region, Ethiopia” – Veterinary Medicine International | DOI: 10.1155/2024/6038724
  • 🧪🐑📅 2015 – “Seroprevalence of Small Ruminant Brucellosis in Werer Agricultural Research Center, Afar Region, North East Ethiopia” – Academia Journal of Microbiology Research
  • 🐂🍖📅 Date not specified – “Effect of Improved Feeding Management on Body Weight Gain and Carcass Characteristics of Afar Bulls for Export Market” – International Journal of Animal Science

Conclusion

Mr. Workisa Chala Bulto’s dedication to veterinary research, his role in vaccine quality control, and his contributions to improving animal health in Ethiopia position him as a strong candidate for the Best Researcher Award. His background in veterinary microbiology, combined with his practical experience and commitment to scientific excellence, makes him well-suited for this recognition.